Skip to main content
. 2021 May 6;17(8):2501–2516. doi: 10.1080/21645515.2021.1887692

Figure 2.

Figure 2.

Overview of formulation experiments to assess the stability of Me and Ru (MeRu) viruses using a scaled-down lab model of NanopatchTM coating/drying process. Flowchart shows the preparation of MeRu samples in various formulations at targeted titer of 102.02 CCID50/disc for each virus (1/10 human dose), loading of samples into 96-well plates with LCP discs, drying by nitrogen, incubation of dried samples under various storage conditions, reconstitution of samples, and then determination of viral titers and genomes by infectivity and genomic RT-qPCR assays. The bottom panel shows the data analysis procedure to determine % losses of viral titers and viral particles during formulation, drying and storage. The values of each sample were normalized to frozen bulk stored at −80°C (100%)